Friend or foe? The elusive role of hepatic stellate cells in liver cancer.


Journal

Nature reviews. Gastroenterology & hepatology
ISSN: 1759-5053
Titre abrégé: Nat Rev Gastroenterol Hepatol
Pays: England
ID NLM: 101500079

Informations de publication

Date de publication:
10 2023
Historique:
accepted: 06 07 2023
pmc-release: 01 04 2024
medline: 22 9 2023
pubmed: 8 8 2023
entrez: 7 8 2023
Statut: ppublish

Résumé

Liver fibrosis is a substantial risk factor for the development and progression of liver cancer, which includes hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA). Studies utilizing cell fate mapping and single-cell transcriptomics techniques have identified quiescent perisinusoidal hepatic stellate cells (HSCs) as the primary source of activated collagen-producing HSCs and liver cancer-associated fibroblasts (CAFs) in HCC and liver metastasis, complemented in iCCA by contributions from portal fibroblasts. At the same time, integrative computational analysis of single-cell, single-nucleus and spatial RNA sequencing data have revealed marked heterogeneity among HSCs and CAFs, with distinct subpopulations displaying unique gene expression signatures and functions. Some of these subpopulations have divergent roles in promoting or inhibiting liver fibrogenesis and carcinogenesis. In this Review, we discuss the dual roles of HSC subpopulations in liver fibrogenesis and their contribution to liver cancer promotion, progression and metastasis. We review the transcriptomic and functional similarities between HSC and CAF subpopulations, highlighting the pathways that either promote or prevent fibrosis and cancer, and the immunological landscape from which these pathways emerge. Insights from ongoing studies will yield novel strategies for developing biomarkers, assessing prognosis and generating new therapies for both HCC and iCCA prevention and treatment.

Identifiants

pubmed: 37550577
doi: 10.1038/s41575-023-00821-z
pii: 10.1038/s41575-023-00821-z
pmc: PMC10671228
mid: NIHMS1943184
doi:

Types de publication

Journal Article Review Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

647-661

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK128289
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA078207
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK121154
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007280
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK136016
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA196521
Pays : United States

Informations de copyright

© 2023. Springer Nature Limited.

Références

Cell. 2014 Sep 25;159(1):80-93
pubmed: 25259922
Cell. 2009 Nov 25;139(5):891-906
pubmed: 19931152
Gastroenterology. 2014 Jul;147(1):41-7
pubmed: 24814904
Nature. 2018 Feb 22;554(7693):544-548
pubmed: 29443960
Front Endocrinol (Lausanne). 2022 Jun 09;13:867940
pubmed: 35757404
Nat Genet. 2015 Sep;47(9):1003-10
pubmed: 26258846
Nat Genet. 2013 Dec;45(12):1474-8
pubmed: 24185513
Nat Commun. 2020 Oct 8;11(1):5077
pubmed: 33033240
Ann Intern Med. 2000 Apr 4;132(7):517-24
pubmed: 10744587
Cell Mol Gastroenterol Hepatol. 2023;15(4):985-999
pubmed: 36708970
Hepatology. 2021 Aug;74(2):667-685
pubmed: 33550587
Neoplasia. 2019 Dec;21(12):1133-1142
pubmed: 31759251
Hepatology. 2015 May;61(5):1547-54
pubmed: 25125077
iScience. 2021 Oct 06;24(11):103233
pubmed: 34755088
Histopathology. 2020 Jan;76(2):182-188
pubmed: 31433515
Mod Pathol. 2021 Feb;34(2):408-416
pubmed: 32860001
Cell Discov. 2023 Mar 6;9(1):25
pubmed: 36878933
PLoS One. 2017 Mar 8;12(3):e0171922
pubmed: 28273155
Microsc Res Tech. 1997 Nov 15;39(4):336-49
pubmed: 9407544
Lancet Oncol. 2020 Jun;21(6):796-807
pubmed: 32416072
J Clin Invest. 2012 Aug;122(8):2911-5
pubmed: 22797301
Oncologist. 2012;17(1):72-9
pubmed: 22180306
Compr Physiol. 2013 Oct;3(4):1473-92
pubmed: 24265236
Hepatology. 2009 Mar;49(3):998-1011
pubmed: 19085956
Nat Commun. 2013;4:2823
pubmed: 24264436
Nature. 2016 Aug 25;536(7617):479-83
pubmed: 27509858
Stem Cell Res Ther. 2020 Sep 29;11(1):425
pubmed: 32993816
Nature. 2021 Apr;592(7854):444-449
pubmed: 33762736
Hepatology. 2014 Apr;59(4):1427-34
pubmed: 24122810
Cancer Res. 2016 Nov 15;76(22):6495-6506
pubmed: 27671678
Cell. 2020 Oct 15;183(2):377-394.e21
pubmed: 32976798
J Hepatol. 2001 Dec;35(6):749-55
pubmed: 11738102
J Clin Invest. 2020 Oct 1;130(10):5380-5396
pubmed: 32663198
JCI Insight. 2019 Jul 23;5:
pubmed: 31335328
Nat Commun. 2018 Dec 4;9(1):5150
pubmed: 30514914
Cancer Discov. 2019 Feb;9(2):282-301
pubmed: 30366930
Science. 2017 Oct 6;358(6359):58-63
pubmed: 28983043
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cell. 2005 May 6;121(3):335-48
pubmed: 15882617
Liver Int. 2019 May;39 Suppl 1:7-18
pubmed: 30882996
Oncogene. 2018 Aug;37(32):4343-4357
pubmed: 29720723
Genes Dev. 2018 Feb 1;32(3-4):244-257
pubmed: 29483153
Nat Med. 2006 Apr;12(4):410-6
pubmed: 16532004
Sci Signal. 2023 May 30;16(787):eadf6696
pubmed: 37253090
Sci Transl Med. 2023 Jan 4;15(677):eadd3949
pubmed: 36599008
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588
pubmed: 32606456
Hepatology. 2014 Nov;60(5):1645-58
pubmed: 25048396
JAMA. 2021 Nov 23;326(20):2031-2042
pubmed: 34762106
J Biol Chem. 2014 Jun 27;289(26):18270-8
pubmed: 24831009
Hepatology. 2007 Jan;45(1):42-52
pubmed: 17187432
J Hepatol. 2020 Nov;73(5):1118-1130
pubmed: 32505533
Nat Cell Biol. 2022 Oct;24(10):1487-1498
pubmed: 36109670
J Hepatol. 2014 Feb;60(2):298-305
pubmed: 24060854
J Hepatol. 2019 Sep;71(3):573-585
pubmed: 31071368
Hepatology. 2021 Nov;74(5):2774-2790
pubmed: 34089528
Cancer Discov. 2021 May;11(5):1248-1267
pubmed: 33323397
Cells. 2019 May 24;8(5):
pubmed: 31137713
Cancer Res. 2013 Jul 1;73(13):3888-901
pubmed: 23598279
Oncotarget. 2017 Sep 8;8(55):93729-93740
pubmed: 29212185
Cancer Discov. 2022 Oct 5;12(10):2350-2371
pubmed: 35853232
J Hepatol. 2015 Jul;63(1):141-7
pubmed: 25678385
Cancer Res. 2008 Aug 15;68(16):6779-88
pubmed: 18701503
Cancer Res. 2016 Jul 15;76(14):4124-35
pubmed: 27216177
Genes Dev. 2015 Jan 1;29(1):1-6
pubmed: 25561492
Cancer Cell. 2021 Apr 12;39(4):548-565.e6
pubmed: 33667385
Cancer Immunol Res. 2014 Feb;2(2):154-66
pubmed: 24778279
Nat Rev Gastroenterol Hepatol. 2021 Apr;18(4):223-238
pubmed: 33349658
Nat Genet. 2012 May 06;44(6):694-8
pubmed: 22561517
Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9448-53
pubmed: 22566629
Nat Commun. 2020 Sep 24;11(1):4841
pubmed: 32973176
Biochem Biophys Res Commun. 1995 Feb 15;207(2):725-31
pubmed: 7864865
J Exp Med. 2017 Mar 6;214(3):579-596
pubmed: 28232471
Gastroenterology. 2012 Apr;142(4):938-46
pubmed: 22240484
Am J Physiol Gastrointest Liver Physiol. 2022 Feb 1;322(2):G234-G246
pubmed: 34941452
Physiol Rev. 2008 Jan;88(1):125-72
pubmed: 18195085
Nat Rev Cancer. 2003 Jun;3(6):453-8
pubmed: 12778135
J Hepatol. 2023 Aug;79(2):552-566
pubmed: 37061196
Cell. 2017 Jun 15;169(7):1327-1341.e23
pubmed: 28622513
PLoS Genet. 2014 Feb 13;10(2):e1004135
pubmed: 24550739
JHEP Rep. 2021 Mar 21;3(3):100278
pubmed: 34027339
Gastroenterology. 2013 Apr;144(4):829-40
pubmed: 23295441
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Cancer Discov. 2019 Aug;9(8):1102-1123
pubmed: 31197017
PLoS One. 2010 Mar 04;5(3):e9504
pubmed: 20209097
Gastroenterology. 2020 May;158(6):1728-1744.e14
pubmed: 31982409
Nature. 2011 Jun 08;474(7350):179-83
pubmed: 21654799
Clin Cancer Res. 2017 Nov 1;23(21):6390-6399
pubmed: 28615370
Arthritis Res Ther. 2006;8(6):R171
pubmed: 17105646
Cancer Cell. 2012 Mar 20;21(3):309-22
pubmed: 22439926
Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):14097-14102
pubmed: 27872290
Nature. 2019 Nov;575(7783):512-518
pubmed: 31597160
Oncotarget. 2017 Aug 3;8(41):70617-70629
pubmed: 29050306
Cell Rep. 2020 May 19;31(7):107628
pubmed: 32433953
Oncogene. 2022 Mar;41(10):1410-1420
pubmed: 35031773
Nat Genet. 2013 Dec;45(12):1470-1473
pubmed: 24185509
Cancer Discov. 2022 Nov 2;12(11):2606-2625
pubmed: 36027053
Oncotarget. 2020 Mar 31;11(13):1186-1201
pubmed: 32284794
Cancer Cell. 2016 Jul 11;30(1):161-175
pubmed: 27411590
Cancer Cell. 2018 Mar 12;33(3):463-479.e10
pubmed: 29455927
Science. 2022 Jan 07;375(6576):91-96
pubmed: 34990237
Cell Rep. 2019 Nov 12;29(7):1832-1847.e8
pubmed: 31722201
Hepatology. 2013 Jan;57(1):339-50
pubmed: 22961591
Nature. 2022 Oct;610(7931):366-372
pubmed: 36198801
Nat Rev Gastroenterol Hepatol. 2017 Jul;14(7):397-411
pubmed: 28487545
Hepatology. 2020 Apr;71(4):1437-1452
pubmed: 31549421
J Clin Invest. 2021 Jun 1;131(11):
pubmed: 33905375
Cancer Cell. 2020 Jun 8;37(6):800-817.e7
pubmed: 32516590
Cancer Cell. 2019 Oct 14;36(4):418-430.e6
pubmed: 31588021
Nat Rev Gastroenterol Hepatol. 2023 Aug;20(8):487-503
pubmed: 36932227
Hepatology. 2020 Dec;72(6):2119-2133
pubmed: 32145072
Cancer Res. 2015 Jul 15;75(14):2800-2810
pubmed: 25979873
Cells. 2021 Aug 19;10(8):
pubmed: 34440898
Gut. 2023 Jan;72(1):129-140
pubmed: 35197323
Anat Rec (Hoboken). 2008 Jun;291(6):693-8
pubmed: 18484616
Sci Transl Med. 2019 Jun 12;11(496):
pubmed: 31189722
Gut. 2012 Oct;61(10):1465-72
pubmed: 22071959
Ann Intern Med. 2008 Sep 16;149(6):399-403
pubmed: 18794559
J Hepatol. 2020 Nov;73(5):1219-1230
pubmed: 32534107
Genome Med. 2022 Jun 27;14(1):68
pubmed: 35761361
Nat Commun. 2015 Jan 22;6:6087
pubmed: 25608663
Lancet Oncol. 2020 May;21(5):671-684
pubmed: 32203698
Int J Cancer. 2014 Feb 15;134(4):778-88
pubmed: 23929039
Nat Cell Biol. 2013 Jun;15(6):637-46
pubmed: 23708000
Gastroenterology. 2015 Oct;149(5):1226-1239.e4
pubmed: 26099527
Nat Cell Biol. 2018 Jul;20(7):766-774
pubmed: 29950570
Hepatology. 2004 Nov;40(5):1062-71
pubmed: 15486925
N Engl J Med. 2004 Oct 7;351(15):1521-31
pubmed: 15470215
Cancer Discov. 2020 Feb;10(2):232-253
pubmed: 31699795
PLoS Genet. 2015 Aug 21;11(8):e1005465
pubmed: 26295846
Nature. 2021 Apr;592(7854):450-456
pubmed: 33762733
Cancer Res. 2020 Sep 15;80(18):3892-3905
pubmed: 32591411
Cell. 2020 Oct 29;183(3):702-716.e14
pubmed: 33125890
J Immunother Cancer. 2019 Jan 25;7(1):19
pubmed: 30683154
Nature. 2017 Feb 16;542(7641):352-356
pubmed: 28166538
Hepatology. 2005 May;41(5):1019-28
pubmed: 15841456
Nat Med. 2014 Apr;20(4):360-7
pubmed: 24633304
Hepatology. 2022 Nov;76(5):1360-1375
pubmed: 35278227
Nat Commun. 2013;4:2218
pubmed: 23887712
Hepatology. 2021 May;73(5):1717-1735
pubmed: 33682185
Hepatol Commun. 2022 Sep;6(9):2538-2550
pubmed: 35726350
Nat Med. 2023 Mar;29(3):562-573
pubmed: 36894650
Gastroenterology. 2017 Sep;153(3):812-826
pubmed: 28624577
Int J Oncol. 2014 Dec;45(6):2303-10
pubmed: 25231346
Cancer Cell. 2021 Jun 14;39(6):866-882.e11
pubmed: 33930309
Gut. 2023 Apr;72(4):736-748
pubmed: 35584893
Cell Regen. 2023 Feb 3;12(1):11
pubmed: 36732412
J Hepatol. 2018 May;68(5):959-969
pubmed: 29360550
Cancer Sci. 2010 Nov;101(11):2325-32
pubmed: 20804499
Cancer Discov. 2013 Jun;3(6):636-47
pubmed: 23558953
Nat Genet. 2017 May;49(5):708-718
pubmed: 28319088
J Immunol. 2012 Oct 15;189(8):3925-35
pubmed: 22972930
Oncotarget. 2016 Apr 19;7(16):22883-92
pubmed: 27015362
Nature. 2021 Nov;599(7886):673-678
pubmed: 34732895
Front Oncol. 2018 Sep 10;8:357
pubmed: 30250825
Nat Commun. 2016 Sep 07;7:12630
pubmed: 27600527
Nat Rev Immunol. 2014 Mar;14(3):181-94
pubmed: 24566915
Nature. 2016 Mar 10;531(7593):253-7
pubmed: 26934227
Hepatology. 1984 May-Jun;4(3):392-403
pubmed: 6373550
Proc Natl Acad Sci U S A. 1985 Dec;82(24):8681-5
pubmed: 3909149
Gastroenterology. 2020 Oct;159(4):1290-1301.e5
pubmed: 32553765
Nat Commun. 2022 Nov 4;13(1):6619
pubmed: 36333338
Nat Med. 2021 Jan;27(1):152-164
pubmed: 33398162
Gastroenterology. 2012 Oct;143(4):1073-83.e22
pubmed: 22750464
Nat Med. 2015 Jun;21(6):591-600
pubmed: 25962123
Hepatology. 2014 Jun;59(6):2397-402
pubmed: 24123296
Nature. 2021 Jun;594(7864):566-571
pubmed: 34079127
Hepatology. 2021 Sep;74(3):1578-1594
pubmed: 33817801
Nat Rev Cancer. 2010 Jan;10(1):9-22
pubmed: 20029421
Sci Rep. 2015 Nov 12;5:16552
pubmed: 26559755
Nat Genet. 2015 May;47(5):505-511
pubmed: 25822088
Cell. 2006 Dec 1;127(5):1015-26
pubmed: 17129785
Hepatol Commun. 2017 Mar 22;1(3):198-214
pubmed: 29404454
Nat Methods. 2017 Sep 29;14(10):935-936
pubmed: 28960196
Gut. 2019 May;68(5):916-927
pubmed: 29970455
Nat Commun. 2018 Oct 22;9(1):4383
pubmed: 30348985
Cancer Res. 2018 Aug 15;78(16):4445-4451
pubmed: 29871934
Cell. 2017 Dec 14;171(7):1611-1624.e24
pubmed: 29198524
Hepatology. 2020 Sep;72(3):965-981
pubmed: 31875970
Nat Commun. 2019 Oct 15;10(1):4688
pubmed: 31615982
Nature. 2021 May;593(7860):575-579
pubmed: 33981032
Eur Surg Res. 2010;44(1):1-12
pubmed: 19864910
J Hepatol. 2022 Nov;77(5):1359-1372
pubmed: 35738508
Cancer Metastasis Rev. 2020 Sep;39(3):783-803
pubmed: 32601975
Cancer Cell. 2005 Sep;8(3):241-54
pubmed: 16169468
Sci Immunol. 2023 Apr 14;8(82):eadd8945
pubmed: 37027478
Int J Mol Sci. 2019 Oct 13;20(20):
pubmed: 31614930
Nat Med. 2006 Aug;12(8):895-904
pubmed: 16892035
Nat Cancer. 2022 Jul;3(7):793-807
pubmed: 35883004
Nat Commun. 2022 Mar 21;13(1):1516
pubmed: 35314685
Cell. 2016 Jun 30;166(1):47-62
pubmed: 27368100
EMBO J. 2020 Oct 1;39(19):e104063
pubmed: 32790115
Mol Cell. 2019 Aug 8;75(3):644-660.e5
pubmed: 31398325
Cell Res. 2015 Jun;25(6):738-52
pubmed: 25998683
J Clin Invest. 2012 Nov;122(11):3914-8
pubmed: 23023701
J Clin Med. 2021 Mar 02;10(5):
pubmed: 33801203
Cell Death Dis. 2021 Mar 11;12(3):260
pubmed: 33707417
Hepatobiliary Surg Nutr. 2017 Feb;6(1):22-34
pubmed: 28261592
Hepatol Commun. 2022 Apr;6(4):821-840
pubmed: 34792289
Hepatology. 2020 Apr;71(4):1467-1473
pubmed: 31997380
JHEP Rep. 2021 Jan 19;3(2):100226
pubmed: 33665585
Nat Med. 2013 Dec;19(12):1617-24
pubmed: 24216753
J Hepatol. 2013 Oct;59(4):880-1
pubmed: 23673137
Nat Methods. 2021 Jan;18(1):9-14
pubmed: 33408395
Clin Cancer Res. 2018 Mar 1;24(5):1190-1201
pubmed: 29269377
Sci Rep. 2017 Sep 8;7(1):11006
pubmed: 28887481
J Clin Invest. 2007 Mar;117(3):539-48
pubmed: 17332881
Hepatology. 2009 Feb;49(2):658-64
pubmed: 19177576
Nat Rev Dis Primers. 2021 Jan 21;7(1):6
pubmed: 33479224
Gastroenterology. 2012 Apr;142(4):1021-1031.e15
pubmed: 22178589
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2324-9
pubmed: 23345421
Sci Rep. 2022 Aug 5;12(1):13484
pubmed: 35931712
Sci Immunol. 2022 Jun 24;7(72):eabl7209
pubmed: 35749514
Clin Cancer Res. 2021 Sep 1;27(17):4669-4679
pubmed: 33827891
Trends Cancer. 2018 Mar;4(3):239-255
pubmed: 29506673
Lancet. 1984 Aug 4;2(8397):241-4
pubmed: 6146805
Nature. 2022 Oct;610(7931):356-365
pubmed: 36198802
Nat Commun. 2022 Aug 6;13(1):4594
pubmed: 35933472
J Clin Invest. 2017 Jan 3;127(1):55-64
pubmed: 28045404
Gastroenterology. 2019 May;156(6):1862-1876.e9
pubmed: 30711630
Cancer Res. 2010 Sep 15;70(18):7073-83
pubmed: 20823158
Nat Cell Biol. 2015 Jun;17(6):816-26
pubmed: 25985394
Front Oncol. 2021 Aug 19;11:648187
pubmed: 34490078

Auteurs

Bruno Cogliati (B)

Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Pathology, School of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo, SP, Brazil.

Chittampalli N Yashaswini (CN)

Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Shuang Wang (S)

Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Daniela Sia (D)

Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Scott L Friedman (SL)

Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Scott.Friedman@mssm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH